Health Care & Life Sciences » Pharmaceuticals | Anhui Fengyuan Pharmaceutical Co. Ltd.

Anhui Fengyuan Pharmaceutical Co. Ltd. A | Balance Sheet

Fiscal year is January-December. All values CNY Millions.
2013
2014
2015
2016
2017
2018
Cash & Short Term Investments
309
168
165
177
276
311
Total Accounts Receivable
361
497
464
655
758
725
Inventories
212
254
270
274
402
461
Other Current Assets
41
35
45
74
58
90
Total Current Assets
923
954
944
1,180
1,494
1,587
Net Property, Plant & Equipment
720
871
906
856
829
807
Total Investments and Advances
25
101
108
130
131
220
Long-Term Note Receivable
121
121
147
159
-
-
Intangible Assets
184
186
189
150
148
178
Other Assets
4
5
5
5
152
199
Total Assets
1,982
2,244
2,305
2,490
2,768
3,008
ST Debt & Current Portion LT Debt
280
463
507
603
730
Accounts Payable
200
280
268
367
367
Income Tax Payable
6
8
6
23
20
Other Current Liabilities
171
193
197
258
372
Total Current Liabilities
656
945
978
1,251
1,490
Long-Term Debt
197
68
59
43
-
Deferred Taxes
4
8
8
8
5
Total Liabilities
856
1,026
1,052
1,312
1,509
Common Equity (Total)
1,014
1,112
1,151
1,153
1,220
Total Shareholders' Equity
1,014
1,112
1,151
1,153
1,220
Total Equity
1,054
1,147
1,184
1,153
1,220
Liabilities & Shareholders' Equity
1,982
2,244
2,305
2,490
2,768
Accumulated Minority Interest
41
34
34
-
-
Non-Equity Reserves
72
71
69
26
39

About Anhui Fengyuan Pharmaceutical Co.

View Profile
Address
Baohe Industrial Park
Hefei Anhui 230051
China
Employees -
Website http://www.bbcayy.com
Updated 07/08/2019
Anhui Fengyuan Pharmaceutical Co., Ltd. is engaged in the pharmaceutical manufacturing and drug retail distribution business. Its business scope includes drug research and development; and the production and sale of large-volume injection, small-volume injection, capsules, granules, powders, bulk drugs, powder injection, freeze-dried powder injection, eye drops, film, tablet, packaging materials and feed additives. The company was founded on August 30, 1997 and is headquartered in Hefei, China.

StatInvestor

Privacy Policy
Feedback

© 2024 StatInvestor All Rights Reserved.